About Oprelvekin
Class: | Thrombopoietin receptor agonist
Use: | Prevention of severe thrombocytopenia and reduction of the need for platelet transfusions in patients undergoing myelosuppressive chemotherapy
Adult dose: | 50 mcg/kg subcutaneously once daily, starting 6 to 24 hours after chemotherapy, for up to 21 days or until platelet count recovery
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended
Side effects: | Common side effects include fluid retent
Drug Class
Thrombopoietin receptor agonist
Uses & Indications
Prevention of severe thrombocytopenia and reduction of the need for platelet transfusions in patients undergoing myelosuppressive chemotherapy
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: Wyeth Pharmaceuticals, U.S.A
Package Size
1ml Vial
Price & Supplier
Price in UAE: AED 1328.60
Dosage Information
Adult Dose
50 mcg/kg subcutaneously once daily, starting 6 to 24 hours after chemotherapy, for up to 21 days or until platelet count recovery
Pediatric Dose
Safety and efficacy not established in pediatric patients; use is not recommended
Side Effects
Common side effects include fluid retention, tachycardia, headache, dizziness, fatigue, and allergic reactions
Contraindications & Precautions
Hypersensitivity to oprelvekin or any component of the formulation; history of severe allergic reactions to other interleukins
Important Warnings
Risk of anaphylaxis; may cause fluid retention leading to heart failure; monitor for signs of fluid overload; use caution in patients with pre-existing cardiac conditions
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.